Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation.

Panarelli NC, Vaughn CP, Samowitz WS, Yantiss RK.

Am J Surg Pathol. 2015 Mar;39(3):313-7. doi: 10.1097/PAS.0000000000000380.

PMID:
25602793
2.

Evaluation of colorectal cancers for Lynch syndrome: practical molecular diagnostics for surgical pathologists.

Samowitz WS.

Mod Pathol. 2015 Jan;28 Suppl 1:S109-13. doi: 10.1038/modpathol.2014.127.

PMID:
25560596
3.

Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum.

Bartley AN, Hamilton SR, Alsabeh R, Ambinder EP, Berman M, Collins E, Fitzgibbons PL, Gress DM, Nowak JA, Samowitz WS, Zafar SY; Members of the Cancer Biomarker Reporting Workgroup, College of American Pathologists.

Arch Pathol Lab Med. 2014 Feb;138(2):166-70. doi: 10.5858/arpa.2013-0231-CP. Epub 2013 Jun 28. No abstract available.

PMID:
23808403
4.

The frequency of previously undetectable deletions involving 3' Exons of the PMS2 gene.

Vaughn CP, Baker CL, Samowitz WS, Swensen JJ.

Genes Chromosomes Cancer. 2013 Jan;52(1):107-12. doi: 10.1002/gcc.22011. Epub 2012 Sep 25.

PMID:
23012243
5.

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

Warren JD, Xiong W, Bunker AM, Vaughn CP, Furtado LV, Roberts WL, Fang JC, Samowitz WS, Heichman KA.

BMC Med. 2011 Dec 14;9:133. doi: 10.1186/1741-7015-9-133.

6.

A PIK3CA pyrosequencing-based assay that excludes pseudogene interference.

Baker CL, Vaughn CP, Samowitz WS.

J Mol Diagn. 2012 Jan;14(1):56-60. doi: 10.1016/j.jmoldx.2011.08.004. Epub 2011 Oct 24.

7.

Epidermal growth factor receptor pathway mutations and colorectal cancer therapy.

Grossmann AH, Samowitz WS.

Arch Pathol Lab Med. 2011 Oct;135(10):1278-82. doi: 10.5858/arpa.2011-0047-RA. Review.

PMID:
21970483
8.

Microsatellite instability and colorectal cancer.

Geiersbach KB, Samowitz WS.

Arch Pathol Lab Med. 2011 Oct;135(10):1269-77. doi: 10.5858/arpa.2011-0035-RA. Review.

PMID:
21970482
9.

Lynch syndrome screening implementation: business analysis by a healthcare system.

Gudgeon JM, Williams JL, Burt RW, Samowitz WS, Snow GL, Williams MS.

Am J Manag Care. 2011 Aug 1;17(8):e288-300.

10.

Avoidance of pseudogene interference in the detection of 3' deletions in PMS2.

Vaughn CP, Hart KJ, Samowitz WS, Swensen JJ.

Hum Mutat. 2011 Sep;32(9):1063-71. doi: 10.1002/humu.21540.

PMID:
21618646
11.

CpG island methylation in colorectal cancer: past, present and future.

Curtin K, Slattery ML, Samowitz WS.

Patholog Res Int. 2011 Apr 12;2011:902674. doi: 10.4061/2011/902674.

12.

Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations.

Curtin K, Ulrich CM, Samowitz WS, Wolff RK, Duggan DJ, Makar KW, Caan BJ, Slattery ML.

Int J Mol Epidemiol Genet. 2011 Jan 1;2(1):1-8. Epub 2010 Nov 5.

13.

Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women.

Curtin K, Samowitz WS, Ulrich CM, Wolff RK, Herrick JS, Caan BJ, Slattery ML.

Nutr Cancer. 2011;63(3):357-66. doi: 10.1080/01635581.2011.535965.

14.

Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.

Vaughn CP, Zobell SD, Furtado LV, Baker CL, Samowitz WS.

Genes Chromosomes Cancer. 2011 May;50(5):307-12. doi: 10.1002/gcc.20854. Epub 2011 Feb 8.

PMID:
21305640
15.

Constitutional mismatch repair-deficiency syndrome presenting as colonic adenomatous polyposis: clues from the skin.

Jasperson KW, Samowitz WS, Burt RW.

Clin Genet. 2011 Oct;80(4):394-7. doi: 10.1111/j.1399-0004.2010.01543.x. Epub 2010 Oct 6.

PMID:
21039432
16.

Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival.

Slattery ML, Curtin K, Poole EM, Duggan DJ, Samowitz WS, Peters U, Caan BJ, Potter JD, Ulrich CM.

Int J Cancer. 2011 Jun 1;128(11):2726-34. doi: 10.1002/ijc.25721. Epub 2010 Nov 28.

17.

Colorectal adenomas and cancer link to chromosome 13q22.1-13q31.3 in a large family with excess colorectal cancer.

Neklason DW, Tuohy TM, Stevens J, Otterud B, Baird L, Kerber RA, Samowitz WS, Kuwada SK, Leppert MF, Burt RW.

J Med Genet. 2010 Oct;47(10):692-9. doi: 10.1136/jmg.2009.076091. Epub 2010 Jun 3.

18.

Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes.

Vaughn CP, Robles J, Swensen JJ, Miller CE, Lyon E, Mao R, Bayrak-Toydemir P, Samowitz WS.

Hum Mutat. 2010 May;31(5):588-93. doi: 10.1002/humu.21230.

PMID:
20205264
19.

Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer.

Curtin K, Samowitz WS, Wolff RK, Ulrich CM, Caan BJ, Potter JD, Slattery ML.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3384-8. doi: 10.1158/1055-9965.EPI-09-0955.

20.

Quantitative evaluation of CpG island methylation in hyperplastic polyps.

Vaughn CP, Wilson AR, Samowitz WS.

Mod Pathol. 2010 Jan;23(1):151-6. doi: 10.1038/modpathol.2009.150. Epub 2009 Oct 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk